Related references
Note: Only part of the references are listed.Hepatocellular Carcinoma
Augusto Villanueva
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Cell type-dependent function of LATS1/2 in cancer cell growth
Wei-Wei Pan et al.
ONCOGENE (2019)
Deferoxamine suppresses esophageal squamous cell carcinoma cell growth far via ERK1/2 mediated mitochondrial dysfunction
Linhua Lan et al.
CANCER LETTERS (2018)
Role of YAP in lung cancer resistance to cisplatin
Juan Song et al.
ONCOLOGY LETTERS (2018)
Sam50 Regulates PINK1-Parkin-Mediated Mitophagy by Controlling PINK1 Stability and Mitochondrial Morphology
Fenglei Jian et al.
CELL REPORTS (2018)
Interplay between YAP/TAZ and Metabolism
Ja Hyun Koo et al.
CELL METABOLISM (2018)
The role of YAP/TAZ activity in cancer metabolic reprogramming
Xiaodong Zhang et al.
MOLECULAR CANCER (2018)
Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway
Zhiqiang Li et al.
CANCER CELL (2018)
Hippo Signaling in the Liver Regulates Organ Size, Cell Fate, and Carcinogenesis
Sachin H. Patel et al.
GASTROENTEROLOGY (2017)
Trends and Patterns of Disparities in Cancer Mortality Among US Counties, 1980-2014
Ali H. Mokdad et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Tetramethylpyrazine blocks TFAM degradation and up-regulates mitochondrial DNA copy number by interacting with TFAM
Linhua Lan et al.
BIOSCIENCE REPORTS (2017)
Yes-associated protein (YAP) expression is involved in epithelial-mesenchymal transition in hepatocellular carcinoma
S. Wang et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2016)
Artemisinin-A Gift from Traditional Chinese Medicine to the World (Nobel Lecture)
Youyou Tu
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Artemisinin inhibits gallbladder cancer cell lines through triggering cell cycle arrest and apoptosis
Jianguang Jia et al.
MOLECULAR MEDICINE REPORTS (2016)
Downregulation of TFAM inhibits the tumorigenesis of non-small cell lung cancer by activating ROS-mediated JNK/p38MAPK signaling and reducing cellular bioenergetics
Deyao Xie et al.
ONCOTARGET (2016)
Artemisinin anti-malarial drugs in China
Zongru Guo
ACTA PHARMACEUTICA SINICA B (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Knockdown of yes-associated protein inhibits proliferation and downregulates large tumor suppressor 1 expression in MHCC97H human hepatocellular carcinoma cells
Cheng Wang et al.
MOLECULAR MEDICINE REPORTS (2015)
The Hippo pathway in chemotherapeutic drug resistance
Yulei Zhao et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
In vivo quantitative phosphoproteomic profiling identifies novel regulators of castration-resistant prostate cancer growth
N. Jiang et al.
ONCOGENE (2015)
Functional and genetic deconstruction of the cellular origin in liver cancer
Jens U. Marquardt et al.
NATURE REVIEWS CANCER (2015)
Colon Cancer Cells Escape 5FU Chemotherapy-Induced Cell Death by Entering Stemness and Quiescence Associated with the c-Yes/YAP Axis
Yasmine Touil et al.
CLINICAL CANCER RESEARCH (2014)
Molecular mechanisms of epithelial-mesenchymal transition
Samy Lamouille et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Artemisinin induces A549 cell apoptosis dominantly via a reactive oxygen species-mediated amplification activation loop among caspase-9,-8 and-3
Weijie Gao et al.
APOPTOSIS (2013)
Overexpression of Yes-associated protein confers doxorubicin resistance in hepatocellullar carcinoma
Xinying Huo et al.
ONCOLOGY REPORTS (2013)
The Global Epidemiology of Hepatocellular Carcinoma: Present and Future
Katherine A. McGlynn et al.
CLINICS IN LIVER DISEASE (2011)
Otto Warburg's contributions to current concepts of cancer metabolism
Willem H. Koppenol et al.
NATURE REVIEWS CANCER (2011)
The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version
Bin Zhao et al.
GENES & DEVELOPMENT (2010)
Artemisinin Directly Targets Malarial Mitochondria through Its Specific Mitochondrial Activation
Juan Wang et al.
PLOS ONE (2010)
Yes-Associated Protein Is an Independent Prognostic Marker in Hepatocellular Carcinoma
Michelle Z. Xu et al.
CANCER (2009)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Expression of Yes-associated protein in common solid tumors
Angela A. Steinhardt et al.
HUMAN PATHOLOGY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2007)
Elucidation of a universal size-control mechanism in Drosophila and mammals
Jixin Dong et al.
CELL (2007)
Artesunate attenuates the growth of human colorectal carcinoma and inhibits hyperactive Wnt/β-catenin pathway
Lin-Na Li et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Evidence for the involvement of carbon-centered radicals in the induction of apoptotic cell death by artemisinin compounds
Amy E. Mercer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach
Lars Zender et al.
CELL (2006)
Share Paper
